Comparative Effect of Combined Strength, Core and Balance Training on Kinesiophobia, Ankle Instability, Functional Outcomes, and Performance in Table Tennis Players With Functional Ankle Instability

June 22, 2026 updated by: Hafsah Gul Khattak, Ibadat International University, Islamabad
This randomized controlled trial investigates the comparative effect of combined strength and balance training versus balance and core training on kinesiophobia (fear of movement), ankle instability, functional outcomes, and athletic performance in adolescent table tennis players with functional ankle instability (FAI). Participants will be randomly allocated into two groups over a 6-week intervention (3 sessions/week). The Experimental Group will receive combined strength and balance training, while the Control Group will receive balance and core training. Outcomes will be measured using validated tools: TSK-17, CAIT, FAAM, Y-Balance Test, Single-Leg Hop Test, T-Test, and Illinois Agility Test.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

51

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Male/female table tennis players aged 15-30 years
  2. Experienced at least one ankle sprain with swelling/pain that interrupted training for >1 day within the last 6 months
  3. Reported sensation of instability of the ankle
  4. Scored ≤25 points on the Cumberland Ankle Instability Tool (CAIT), indicating functional ankle instability

Exclusion Criteria:

  1. History of ankle fracture or surgery
  2. Any fracture of lower limb history
  3. Any neurological or vestibular disorders
  4. Other injuries of lower limb affecting performance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: Combined Strength and Balance Training

Participants will receive a 6-week combined strength and balance training program (3 sessions/week, 40-45 min).

Strength Component: Theraband Dorsiflexion (3×12), Theraband Eversion (3×12), Heel Raises progressing to single-leg (3×12), Forward Lunges (3×10 each leg).

Balance Component: Single-Leg Stance Eyes Open→Closed (3×30 sec), Wobble Board Standing (3×30 sec), Y-Balance Reach (3 trials each direction).

Weekly progression: Week 1-2 basic stable surface exercises, Week 3-4 increased repetitions, Week 5-6 single-leg variations introduced.

A structured 6-week exercise program combining ankle strengthening exercises (Theraband resistance training, heel raises, lunges) with dynamic balance training (single-leg stance, wobble board, Y-balance drills). Sessions last 40-45 minutes and are conducted 3 times per week. Warm-up: 5-7 min light jogging/dynamic mobility. Main Training: 30 min combined strength and balance work. Cool-down: 5 min static stretching.
Active Comparator: Control Group: Balance and Core Training

Participants will receive a 6-week balance and core training program (3 sessions/week, 40-45 min).

Balance Component: Single-Leg Stance Firm→Foam (3×30 sec), Tandem Walking (3×10 m), Y-Balance Drill (3 trials each direction).

Core Component: Plank Hold (3×20 sec), Side Plank each side (3×15 sec), Dead Bug Exercise (3×10 reps).

Weekly progression: Week 1-2 basic level, Week 3-4 increased repetitions, Week 5-6 maintained progression.

A structured 6-week program combining balance training (single-leg stance on firm and foam surfaces, tandem walking, Y-balance drills) with core stabilization exercises (plank, side plank, dead bug). Sessions last 40-45 minutes, 3 times per week with the same warm-up and cool-down structure as the experimental group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Kinesiophobia - Tampa Scale for Kinesiophobia (TSK-17)
Time Frame: Baseline (Week 0) and Post-intervention (Week 6)
17-item self-report questionnaire measuring fear of movement and re-injury. Good internal consistency (Cronbach's α = 0.70-0.86) and test-retest reliability (ICC = 0.72-0.90). Reduced scores indicate decreased kinesiophobia.
Baseline (Week 0) and Post-intervention (Week 6)
Ankle Instability - Cumberland Ankle Instability Tool (CAIT)
Time Frame: Baseline (Week 0) and Post-intervention (Week 6)
Validated questionnaire assessing functional ankle instability severity. Excellent test-retest reliability (ICC = 0.96) and internal consistency (Cronbach's α = 0.83). Increased post-intervention scores indicate improved perceived ankle stability
Baseline (Week 0) and Post-intervention (Week 6)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Ability - Foot and Ankle Ability Measure (FAAM)
Time Frame: Baseline (Week 0) and Post-intervention (Week 6)
Self-reported tool assessing functional limitations in foot and ankle disorders. Excellent internal consistency (α = 0.89-0.98) and reliability (ICC = 0.84-0.92) for ADL and Sports subscales. Increased scores indicate improved functional ability
Baseline (Week 0) and Post-intervention (Week 6)
Dynamic Balance - Y Balance Test (YBT)
Time Frame: Baseline (Week 0) and Post-intervention (Week 6)
Measures dynamic balance and lower limb neuromuscular control. Excellent test-retest reliability (ICC = 0.85-0.91). Reach distances normalized to limb length. Increased post-intervention reach distance indicates improved ankle stability.
Baseline (Week 0) and Post-intervention (Week 6)
Functional Performance - Single-Leg Hop Test
Time Frame: Baseline (Week 0) and Post-intervention (Week 6)
Reliable measure of lower limb strength, dynamic stability, and functional performance (ICC = 0.85-0.95). Increased hop distance and improved landing control indicate enhanced neuromuscular function.
Baseline (Week 0) and Post-intervention (Week 6)
Agility and Performance - T-Test and Illinois Agility Test
Time Frame: Baseline (Week 0) and Post-intervention (Week 6)
Valid and reliable measures of agility and change-of-direction speed. T-Test (ICC = 0.90-0.98), Illinois Agility Test (ICC = 0.88-0.96). Reduced completion time indicates improved dynamic stability and neuromuscular control.
Baseline (Week 0) and Post-intervention (Week 6)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Hafsah Gul Khattak, DPT, MSNMPT, Ibadat International University, Islamabad (Iiui)

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

October 1, 2026

Study Registration Dates

First Submitted

June 22, 2026

First Submitted That Met QC Criteria

June 22, 2026

First Posted (Actual)

June 26, 2026

Study Record Updates

Last Update Posted (Actual)

June 26, 2026

Last Update Submitted That Met QC Criteria

June 22, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IIUI/RERC/ADT/2026/05/261

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe